Related references
Note: Only part of the references are listed.Systemic cytotoxic and biologic therapies for colorectal cancer liver metastases: expert consensus statement
Bryan M. Clary et al.
HPB (2013)
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement
Roderich E. Schwarz et al.
HPB (2013)
Biologic therapies in the metastatic colorectal cancer treatment continuum - Applying current evidence to clinical practice
Marc Peeters et al.
CANCER TREATMENT REVIEWS (2012)
Matched-Pair Comparison of Radioembolization Plus Best Supportive Care Versus Best Supportive Care Alone for Chemotherapy Refractory Liver-Dominant Colorectal Metastases
Ricarda Seidensticker et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
An Update on the Current and Emerging Targeted Agents in Metastatic Colorectal Cancer
Edward Chu
CLINICAL COLORECTAL CANCER (2012)
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study
Kjell Magne Tveit et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Radioembolization versus Standard Care of Hepatic Metastases: Comparative Retrospective Cohort Study of Survival Outcomes and Adverse Events in Salvage Patients
Lourens Bester et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
No Survival Benefit from Adding Cetuximab or Panitumumab to Oxaliplatin-Based Chemotherapy in the First-Line Treatment of Metastatic Colorectal Cancer in KRAS Wild Type Patients: A Meta-Analysis
Si-wei Zhou et al.
PLOS ONE (2012)
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Radioembolization in Combination with Systemic Chemotherapy as First-line Therapy for Liver Metastases from Colorectal Cancer
Suzanne Kosmider et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2011)
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Timothy S. Maughan et al.
LANCET (2011)
Pre-operative chemotherapy for colorectal cancer liver metastases: an update of recent clinical trials
G. Nasti et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy
Alain Hendlisz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2009)
Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
Carsten Bokemeyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
Leonard B. Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
Bruce J. Giantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Developing strategies for liver metastases from colorectal cancer
Rene Adam
SEMINARS IN ONCOLOGY (2007)
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy
Ricky A. Sharma et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases
Eric Van Cutsem et al.
EUROPEAN JOURNAL OF CANCER (2006)
Short- and-long term results of intraoperative radiofrequency ablation of liver metastases
G Navarra et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2005)
Neoadjuvant treatment of unresectable colorectal liver metastases:: correlation between tumour response and resection rates
G Folprecht et al.
ANNALS OF ONCOLOGY (2005)
A phase I-II study of weekly oxaliplatin, 5-fiuorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer
C Aschele et al.
ANNALS OF ONCOLOGY (2005)
Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: A prospective study
E Berber et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Oxaliplatin-associated neuropathy: A review
RJ Cersosimo
ANNALS OF PHARMACOTHERAPY (2005)
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer:: A randomized GERCOR study
C Tournigand et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Tumor progression while on chemotherapy - A contraindication to liver resection for multiple colorectal metastases?
R Adam et al.
ANNALS OF SURGERY (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Randomised phase 2 trial of SIR-Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer
G Van Hazel et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
RM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A 'modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer
SL Cheeseman et al.
BRITISH JOURNAL OF CANCER (2002)
Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: Report of a clinical trial for patients with esophageal cancer
NI Khushalani et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Trends in long-term survival following liver resection for hepatic colorectal metastases
MA Choti et al.
ANNALS OF SURGERY (2002)
Addition of oxaliplatin to continuous fluorouracil, L-folinic acid, and concomitant radiotherapy in rectal cancer:: The Lyon R 97-03 Phase I trial
G Freyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Randomised trial of SIR-Spheres((R)) plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer
B Gray et al.
ANNALS OF ONCOLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
LB Saltz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
